Scientists in China have successfully engineered a specialized yeast strain capable of significantly boosting the production of palmitoleic acid, an omega-7 fatty acid renowned for its health properties such as anti-inflammatory effects and metabolic support. This scientific achievement opens up avenues for more cost-effective and efficient production of this beneficial nutrient, reducing the dependency on scarce plant sources traditionally used for its extraction.
The research team from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT), affiliated with the Chinese Academy of Sciences, detailed their innovative approach in the journal Biotechnology for Biofuels and Bioproducts. By harnessing the potential of Saccharomyces cerevisiae, a yeast strain commonly employed in baking and brewing, the scientists were able to overcome the limitations posed by its naturally low production of palmitoleic acid, rendering it unsuitable for large-scale manufacturing until now.
Employing a two-step methodology, the researchers initiated the creation of a substantial pool of mutant yeast cells utilizing zeocin, a specialized antibiotic, alongside Atmospheric and Room Temperature Plasma (ARTP) technology, inducing random genetic alterations within the yeast cells. Subsequently, the adoption of the FlowRACS system, a sophisticated laser-based flow cytometry apparatus, facilitated the identification and selection of the most efficient cells, with the mutant yeast strain MU2R48 emerging as a star performer, exhibiting a remarkable 40.26% lipid content—a significant improvement of nearly 31% over its original counterpart, while maintaining robust growth characteristics, making it a promising candidate for industrial applications.
The implementation of the FlowRACS system is particularly noteworthy for its ability to scrutinize the inherent chemical composition of individual cells through light-based analysis, enabling researchers to pinpoint optimal strains without resorting to genetic modifications or external additives. To unravel the mechanisms underlying the heightened fat production in the mutant yeast strain, a comprehensive “multi-omics” analysis was conducted, delving into genetic, metabolic, and protein-level alterations. The investigation revealed that MU2R48 had upregulated critical energy and sugar-processing pathways responsible for generating essential building blocks like acetyl-CoA and NADPH, crucial for fatty acid synthesis, while simultaneously downregulating fat-burning pathways, enhancing overall fat accumulation.
This groundbreaking discovery underscores the potential of cutting-edge tools in enhancing the functionality of natural organisms for diverse applications in food, pharmaceuticals, and industrial sectors, circumventing the need for genetically modified organisms. The newfound yeast strain paves the way for future advancements in the efficient production of palmitoleic acid within manufacturing facilities, offering a viable alternative to sourcing it from scarce botanical sources like sea buckthorn and macadamia nuts. The research signifies a significant stride in biotechnological innovation, showcasing the transformative power of genetic engineering in augmenting the production of valuable compounds from natural sources.
– The engineered yeast strain MU2R48 demonstrates a substantial increase in lipid content, making it a promising candidate for large-scale production of palmitoleic acid.
– Advanced techniques such as FlowRACS enable precise selection of high-performing yeast mutants without the need for genetic modifications or foreign materials.
– Multi-omics analysis provides insights into the genetic and metabolic adaptations that enhance fatty acid production in the mutant yeast strain.
– The study highlights the potential of utilizing biotechnological advancements to optimize natural organisms for industrial applications, reducing reliance on scarce plant resources for nutrient extraction.
Tags: biofuels, yeast, bioprocess
Read more on knowridge.com